麗珠醫藥(01513.HK)註銷部分股票期權
格隆匯12月18日丨麗珠醫藥(01513.HK)公吿,鑑於首次授予的25名激勵對象因個人原因離職,已不符合激勵條件,根據激勵計劃“第十三章公司或激勵對象發生異動的處理”的規定,以及臨時股東大會、A股類別股東會及H股類別股東會授權董事會辦理激勵計劃相關事宜,公司擬對上述25名激勵對象所持有的已獲授但不符合行權條件的361,000份股票期權進行註銷。
經過本次註銷後,首次授予的股票期權數量由17,973,500份調整為17,612,500份,首次授予激勵對象人數由1,026名調整為1,001名。
除上述調整及註銷外,激勵計劃的所有其他條文與條件均保持不變。
首次授予第一個行權期符合行權條件。首次授予股票期權的授予日為2022年11月7日,授予登記完成日為2022年11月23日,首次授予股票期權的第一個等待期已於2023年11月22日屆滿。董事會認為首次授予第一個行權期的行權條件已經成就,同意符合行權條件的1,001名激勵對象在第一個行權期可行權7,045,000份股票期權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.